Immunoenzymatic and biochip array profiling of the biomarkers of inflammation and hemostatic activation processes in ESRD

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Jjais RichardsJawed Fareed

Abstract

There is a high incidence of mortality due to cardiovascular events seen in patients with end-stage renal disease (ESRD) undergoing hemodialysis. Through utilization of biochip microarrays and enzyme-linked immunosorbent assay methods, we assessed various cardiac, inflammatory, thrombotic, and cerebral biomarkers to determine their roles in the hemostatic activation or inflammatory processes in ESRD. In this study, 72 patients on maintenance hemodialysis were recruited and 53 normal healthy male and female adults volunteers. Blood samples from patients with ESRD were drawn prior to maintenance hemodialysis. Of the 15 statistically significant biomarkers, 10 were elevated in the ESRD group, most notably soluble tumor necrosis factor receptor 1, heart-type fatty acid binding protein, and von Willebrand factor activity. These results are consistent with previously reported studies proposing ESRD represents a poly-pathologic process with the activation of hemostatic and inflammatory processes, which contribute to the significant sequelae of cardiovascular disease seen in these patients.

References

Jun 8, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C H BoltonJ H Pinkney
Apr 16, 2003·The American Journal of the Medical Sciences·Allan J Collins
Sep 7, 2004·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Michael W DonninoMichael C Tomlanovich
Jan 25, 2005·Lancet·A Meguid El Nahas, Aminu K Bello
Feb 26, 2010·The American Journal of Clinical Nutrition·Biruh T Workeneh, William E Mitch
Dec 17, 2010·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Kelly NelsonVinod Bansal
Feb 24, 2011·Journal of Thrombosis and Haemostasis : JTH·M C van SchieF W G Leebeek
Aug 30, 2011·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Rachael DavisJawed Fareed
Mar 1, 2007·Indian Journal of Clinical Biochemistry : IJCB·P K Nigam
Sep 3, 2013·International Immunopharmacology·Krisztina FutosiAttila Mócsai

❮ Previous
Next ❯

Citations

Oct 11, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ying-Mei FengJan A Staessen

❮ Previous
Next ❯

Methods Mentioned

BETA
blood draw
sandwich immunoassay
ELISA
enzyme-linked immunosorbent assay

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Related Papers

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Rachael DavisJawed Fareed
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Blanche M ChaversCharles A Herzog
The Mount Sinai Journal of Medicine, New York
Ajith P NairMichael J Robbins
© 2022 Meta ULC. All rights reserved